Evidence map›Paper›PMID 42416130›Full record

ArticleJournal of clinical practice and research2026

Second Screening for Celiac Disease in First-Degree Relatives of Pediatric Index Cases: A Single-Center Observational Study.

Selcuk Teke, Yasin Maruf Ergen, Birce Izgi Akcay, Remzi Ekici, Edibe Gozde Basaran, Necati Balamtekin

Abstract read
In one paragraph

Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Selcuk TekeDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.
Yasin Maruf ErgenDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.
Birce Izgi AkcayDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.
Remzi EkiciDivision of Gastroenterology, Department of Internal Medicine, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.
Edibe Gozde BasaranDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.
Necati BalamtekinDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Gülhane Training and Research Hospital, Health Science University, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study investigated new seropositivity detected during repeat screening among first-degree relatives of pediatric index cases with celiac disease (CD) who were seronegative at initial screening. Materials and Methods: This single-center, observational, family-based screening study was conducted at a tertiary pediatric gastroenterology center. First-degree relatives of 117 pediatric index cases with biopsy-confirmed CD were invited for screening. CD screening was performed using tissue transglutaminase immunoglobulin A, with tissue transglutaminase immunoglobulin G used in cases of low total immunoglobulin A. Individuals with seropositivity underwent upper gastrointestinal endoscopy with duodenal biopsy. Histopathologic findings were evaluated according to the Marsh classification. Among participants with negative initial serology, those whose first screening had been performed at least 1 year earlier underwent repeat serologic screening. Results: Of the 462 invited first-degree relatives, 376 participated in the initial screening. Seropositivity was detected in 5.6% of participants, and biopsy-confirmed CD was established in 5.0%. Among the 355 individuals with negative initial serology, 101 underwent repeat screening after a median interval of 3.0 years. New seropositivity was detected in 4 of these 101 individuals [3.9%; exact binomial 95% CI: 1.1-9.8], and all had biopsy-confirmed CD. Three of the newly identified cases were siblings who had been screened in early childhood. No significant association was found between the presence of symptoms and serologic positivity at either screening. Conclusion: First-degree relatives of pediatric patients with CD represent a high-risk group in whom new seropositivity may emerge over time. Repeat screening, particularly in relatives first screened during early childhood, may improve case detection.

Indexed as

Biopsydietearly diagnosisendoscopygluten-freeMarsh classification

Identifiers

PMID42416130
PMCPMC13338828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.